Placebo PH20 SC – prefilled syringe (placebo to Efgartigimod PH20 SC – prefilled syringe), Efgartigimod
ARGX-113-2302
Phase 2 small_molecule active
Quick answer
Placebo PH20 SC – prefilled syringe (placebo to Efgartigimod PH20 SC – prefilled syringe), Efgartigimod for Antibody-Mediated Rejection is a Phase 2 program (small_molecule) at Argenx with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Argenx
- Indication
- Antibody-Mediated Rejection
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active